Key result
Thiazolidinediones (rosiglitazone and pioglitazone) act as insulin sensitizers in patients with PCOS, decreasing free fatty acid levels and visceral fat mass.
Why the study?
What are the effects of thiazolidinediones compared to metformin and oral contraceptives in patients with PCOS?
What are the effects of thiazolidinediones compared to metformin and oral contraceptives in patients with PCOS?
This review summarizes the effects of thiazolidinediones in PCOS and provides recommendations for their clinical use compared to metformin and oral contraceptives.
Answers are grounded in this paper and cite their sources.
May support metabolic benefits in PCOS; leaves open comparative efficacy versus metformin or contraceptives.
Polycystic ovary syndrome (PCOS) is characterised by anovulation, hyperandrogenism, and polycystic ovaries. Fifty percent of patients fulfil the criteria for the metabolic syndrome. The pathogenesis of PCOS may be looked as a vicious cycle involving hyperandrogenemia, central obesity, and insulin resistance and medical treatment should aim at breaking this cycle. Lifestyle intervention, oral contraceptives, and insulin sensitises such as metformin are the most commonly used treatment modalities. The thiazolidinediones rosiglitazone and pioglitazone were recently applied as insulin sensitising treatment in patients with PCOS. Thiazolidinediones activate the transcription of genes that affect glucose and lipid metabolism mediating decreased free fatty acid levels and decreased visceral fat mass. In the present article, we give an overview of the diverse effects of glitazone treatment in patients with PCOS. We review the studies comparing glitazone versus metformin and oral contraceptive treatment and recommend which patients should be treated with glitazones in daily praxis.
No takes yet. Share an insight, caveat, or question.
Glintborg et al. (2010) conducted a review in Polycystic ovary syndrome (PCOS). Thiazolidinediones (rosiglitazone and pioglitazone) vs. Metformin and oral contraceptives was evaluated. Thiazolidinediones (rosiglitazone and pioglitazone) act as insulin sensitizers in patients with PCOS, decreasing free fatty acid levels and visceral fat mass.
Synapse has enriched 10 related papers. Consider them for comparative context: